PROVIDER PROFILE · NPI 1760618250
Johnathan WarminskiMD
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
5,272
Unique beneficiaries
—
Total services
120,191
Distinct HCPCS
22
Medicare payment
$5.1M
Peer benchmark
Total Medicare services vs. 1,238 Ophthalmology providers in TX — top quintile (cohort median 1,864).
PRESCRIBING · PART D · 2024
Total Rx claims
475
Beneficiaries
—
Total drug cost
$25K
Distinct drugs
9
Brand share
62.1%
Top prescribed drugs
Tobramycin/Dexamethasone115 claims
Promethazine Hcl80 claims
Prednisolone Acetate77 claims
Neomycin/Polymyxin B/Dexametha47 claims
Acetaminophen With Codeine46 claims
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
100.0
Cost
0.0
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
1.05%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$2K
Payment records
86
By payment type
Food and Beverage$2K
Top paying entities
Food and Beverage$2K
REFERRAL NETWORK
Where Johnathan Warminski's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Lyle Freedman Ophthalmology · Ft Worth, TX | 20 | 45 |
| Laboratory Corporation Of America Clinical Laboratory · Dallas, TX | 15 | 48 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE